ECM
NVO

Exchange Capital Management’s Novo Nordisk NVO Stock Holding History

Exchange Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-180
Closed -$4K – 219
2018
Q3 		$4K Hold
180
– – ﹤0.01% 274
2018
Q2 		$4K Hold
180
– – ﹤0.01% 238
2018
Q1 		$4K Buy
+180
New +$4.73K ﹤0.01% 224
2015
Q1 		– Sell
-140
Closed -$3K – 249
2014
Q4 		$3K Buy
+140
New +$3.13K ﹤0.01% 241

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Exchange Capital Management's NVO Position: Q4 2018 in Review

Exchange Capital Management sold out of Novo Nordisk (NVO) in Q4 2018, closing a stake of 180 shares — an estimated $4K sold.

Exchange Capital Management first reported a position in NVO in Q4 2014 and held it in 4 quarters. The position peaked at $4K in Q3 2018. 550 funds tracked by Wall St. Rank hold NVO as of Q4 2018.

  • Exchange Capital Management reported no remaining Novo Nordisk position as of Q4 2018 after selling out during the quarter.
  • Exchange Capital Management sold 180 Novo Nordisk shares in Q4 2018, an estimated $4K.
  • Exchange Capital Management first reported a position in Novo Nordisk in Q4 2014 and held it in 4 quarters.
  • Exchange Capital Management's Novo Nordisk position peaked at $4K in Q3 2018.
  • 550 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2018.

Based on Exchange Capital Management's 13F filing for Q4 2018, filed 1 Feb 2019.